Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Claya vs CoraDoc

Claya
Graded #264

Lower grade

vs+14
CoraDoc
Graded #49

Higher grade

The verdict

CoraDoc takes it — 76.8/100 to 62.8/100.

CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc is a nationwide (all 50 states) doctor-prescribed GLP-1 weight-loss telehealth service offering compounded semaglutide (from $99/mo) and tirzepatide (from $165/mo) as flat, no-subscription programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCoraDoc +54
42
96
Dose & formulationClaya +3
75
72
Clinical oversightClaya +3
82
79
Labs & monitoringEven
53
53
FulfillmentCoraDoc +9
67
76
Contract termsCoraDoc +8
61
69
Claya · left barCoraDoc · right bar

The numbers

MetricClayaCoraDoc
WeighScore62.8/10076.8/100
GradeCC
Scorecard rank#264#49
Semaglutide$299/mo (compounded)$99/mo (all doses, compounded)
Tirzepatide$299/mo (compounded)$165/mo (all doses, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only
Claya

Graded #264 · C

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Where it loses points

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage
CoraDoc

Graded #49 · C

Strengths

  • Low flat pricing — compounded semaglutide from $99/mo, tirzepatide from $165/mo, no subscription
  • Triple Free Promise: free provider visit, free 2-day shipping, and free supplies included
  • Available in all 50 states; HSA/FSA plus Afterpay/Klarna/Affirm; full refund if not approved
  • Full legal suite published (Terms, Privacy, Refund Policy); board-certified providers

Where it loses points

  • Lowest $99 price is the longest-commitment tier (programs range about $99-$199/mo)
  • Compounding pharmacy partner not named
  • 'LegitScript Certified' is stated prominently but was not independently verified here
  • Operating legal entity not clearly named on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard